Hematology Diagnostic Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the hematology diagnostic market looks promising with opportunities in hospitals and diagnostic labs. The global hematology diagnostic market is expected to grow with a CAGR of 5%-7% from 2020 to 2025. The major drivers for this market are development of technologically advanced hematology analyzers, increasing usage of flow cytometry in hematology testing, and development of high-sensitivity point-of-care hematology analyzers.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global hematology diagnostic market report, please download the report brochure.
In this market, consumables is the largest product of hematology diagnostic, whereas hospitals is the largest end user. Growth in various segments of the hematology diagnostic market are given below:
The study includes trends and forecast for the global hematology diagnostic market by product, test, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
InstrumentConsumables
By Test [Value ($ Million) shipment analysis for 2014 – 2025]:
CBCHemoglobinHematocritRBCWBCReticulocytesPlatelet FunctionCRPNeutrophil FunctionBone MarrowDPG
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
HospitalsDiagnostic LabsOthers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the hematology diagnostic companies profiled in this report include Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Boule Diagnostics, Horiba, Mindray Medical, Nihon Kohden Corporation, Roche Diagnostics, Siemens Healthcare, and Sysmex Corporation.
Lucintel forecasts that consumables will remain the largest product segment over the forecast period due to rise in diagnosis of blood disorders and other infections and increasing test volume owing to rising awareness and early detection.
Within this market, hospitals will remain the largest end user segment over the forecast period due to high patient influx in hospitals and a growing number of registered hospitals across the globe.
North America will remain the largest region over the forecast period due to technological advancements in instruments, ease of usage, and favorable reimbursement scenario.
Features of the Global Hematology Diagnostic Market
Market Size Estimates: Global hematology diagnostic market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global hematology diagnostic market size by various segments, such as product, test, and end user in terms of value.Regional Analysis: Global hematology diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, test, end user, and region for the global hematology diagnostic market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global hematology diagnostic market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global hematology diagnostic market by product (instrument and consumables), test (CBC (hemoglobin, hematocrit, and RBC), WBC, reticulocytes, platelet function, CRP, neutrophil function, bone marrow, and DPG), end user (hospitals, diagnostic labs, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global hematology diagnostic market?
Q.5 What are the business risks and threats to the global hematology diagnostic market?
Q.6 What are the emerging trends in this hematology diagnostic market and the reasons behind them?
Q.7 What are some changing demands of customers in this hematology diagnostic market?
Q.8 What are the new developments in this hematology diagnostic market? Which companies are leading these developments?
Q.9 Who are the major players in this hematology diagnostic market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this hematology diagnostic market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global hematology diagnostic market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Instrument and Consumables), Test (CBC (Hemoglobin, Hematocrit, and RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, and DPG), and End User (Hospitals, Diagnostic Labs, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the hematology diagnostic market looks promising with opportunities in hospitals and diagnostic labs. The global hematology diagnostic market is expected to grow with a CAGR of 5%-7% from 2020 to 2025. The major drivers for this market are development of technologically advanced hematology analyzers, increasing usage of flow cytometry in hematology testing, and development of high-sensitivity point-of-care hematology analyzers.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global hematology diagnostic market report, please download the report brochure.
In this market, consumables is the largest product of hematology diagnostic, whereas hospitals is the largest end user. Growth in various segments of the hematology diagnostic market are given below:
The study includes trends and forecast for the global hematology diagnostic market by product, test, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
InstrumentConsumables
By Test [Value ($ Million) shipment analysis for 2014 – 2025]:
CBCHemoglobinHematocritRBCWBCReticulocytesPlatelet FunctionCRPNeutrophil FunctionBone MarrowDPG
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
HospitalsDiagnostic LabsOthers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the hematology diagnostic companies profiled in this report include Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Boule Diagnostics, Horiba, Mindray Medical, Nihon Kohden Corporation, Roche Diagnostics, Siemens Healthcare, and Sysmex Corporation.
Lucintel forecasts that consumables will remain the largest product segment over the forecast period due to rise in diagnosis of blood disorders and other infections and increasing test volume owing to rising awareness and early detection.
Within this market, hospitals will remain the largest end user segment over the forecast period due to high patient influx in hospitals and a growing number of registered hospitals across the globe.
North America will remain the largest region over the forecast period due to technological advancements in instruments, ease of usage, and favorable reimbursement scenario.
Features of the Global Hematology Diagnostic Market
Market Size Estimates: Global hematology diagnostic market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global hematology diagnostic market size by various segments, such as product, test, and end user in terms of value.Regional Analysis: Global hematology diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, test, end user, and region for the global hematology diagnostic market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global hematology diagnostic market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global hematology diagnostic market by product (instrument and consumables), test (CBC (hemoglobin, hematocrit, and RBC), WBC, reticulocytes, platelet function, CRP, neutrophil function, bone marrow, and DPG), end user (hospitals, diagnostic labs, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global hematology diagnostic market?
Q.5 What are the business risks and threats to the global hematology diagnostic market?
Q.6 What are the emerging trends in this hematology diagnostic market and the reasons behind them?
Q.7 What are some changing demands of customers in this hematology diagnostic market?
Q.8 What are the new developments in this hematology diagnostic market? Which companies are leading these developments?
Q.9 Who are the major players in this hematology diagnostic market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this hematology diagnostic market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global hematology diagnostic market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Instrument and Consumables), Test (CBC (Hemoglobin, Hematocrit, and RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, and DPG), and End User (Hospitals, Diagnostic Labs, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Hematology Diagnostic Market Trends and Forecast
3.3: Global Hematology Diagnostic Market by Product
3.3.1: Instrument
3.3.2: Comsumables
3.4: Global Hematology Diagnostic Market by Test
3.4.1: CBC
3.4.1.1: Hemoglobin
3.4.1.2: Hematocrit
3.4.1.3: RBC
3.4.2: WBC
3.4.3: Reticulocytes
3.4.4: Platelet Function
3.4.5: CRP
3.4.6: Neutrophil Function
3.4.7: Bone Marrow
3.4.8: DPG
3.5: Global Hematology Diagnostic Market by End User
3.5.1: Hospitals
3.5.2: Diagnostic Labs
3.5.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Hematology Diagnostic Market by Region
4.2: North American Hematology Diagnostic Market
4.2.1: Market by Product: Instrument and Consumables
4.2.2: Market by Test: CBC (Hemoglobin, Hematocrit, and RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, and DPG
4.2.3: Market by End User: Hospitals, Diagnostic Labs, and Others
4.2.4: The United States Hematology Diagnostic Market
4.2.5: The Canadian Hematology Diagnostic Market
4.2.6: The Mexican Hematology Diagnostic Market
4.3: European Hematology Diagnostic Market
4.3.1: Market by Product: Instrument and Consumables
4.3.2: Market by Test: CBC (Hemoglobin, Hematocrit, and RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, and DPG
4.3.3: Market by End User: Hospitals, Diagnostic Labs, and Others
4.3.4: The United Kingdom Hematology Diagnostic Market
4.3.5: The Spanish Hematology Diagnostic Market
4.3.6: The German Hematology Diagnostic Market
4.3.7: The French Hematology Diagnostic Market
4.4: APAC Hematology Diagnostic Market
4.4.1: Market by Product: Instrument and Consumables
4.4.2: Market by Test: CBC (Hemoglobin, Hematocrit, and RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, and DPG
4.4.3: Market by End User: Hospitals, Diagnostic Labs, and Others
4.4.4: The Chinese Hematology Diagnostic Market
4.4.5: The Indian Hematology Diagnostic Market
4.4.6: The Japanese Hematology Diagnostic Market
4.5: ROW Hematology Diagnostic Market
4.5.1: Market by Product: Instrument and Consumables
4.5.2: Market by Test: CBC (Hemoglobin, Hematocrit, and RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, and DPG
4.5.3: Market by End User: Hospitals, Diagnostic Labs, and Others
4.5.5: Brazilian Hematology Diagnostic Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Hematology Diagnostic Market by Product
7.1.2: Growth Opportunities for the Global Hematology Diagnostic Market by Test
7.1.3: Growth Opportunities for the Global Hematology Diagnostic Market by End User
7.1.4: Growth Opportunities for the Global Hematology Diagnostic Market by Region
7.2: Emerging Trends in the Global Hematology Diagnostic Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Hematology Diagnostic Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hematology Diagnostic Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Abbott Laboratories
8.2: Beckman Coulter
8.3: Bio-Rad Laboratories
8.4: Boule Diagnostics
8.5: Horiba
8.6: Mindray Medical
8.7: Nihon Kohden Corporation
8.8: Roche Diagnostics
8.9: Siemens Healthcare
8.10: Sysmex Corporation
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Hematology Diagnostic Market Trends and Forecast
3.3: Global Hematology Diagnostic Market by Product
3.3.1: Instrument
3.3.2: Comsumables
3.4: Global Hematology Diagnostic Market by Test
3.4.1: CBC
3.4.1.1: Hemoglobin
3.4.1.2: Hematocrit
3.4.1.3: RBC
3.4.2: WBC
3.4.3: Reticulocytes
3.4.4: Platelet Function
3.4.5: CRP
3.4.6: Neutrophil Function
3.4.7: Bone Marrow
3.4.8: DPG
3.5: Global Hematology Diagnostic Market by End User
3.5.1: Hospitals
3.5.2: Diagnostic Labs
3.5.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Hematology Diagnostic Market by Region
4.2: North American Hematology Diagnostic Market
4.2.1: Market by Product: Instrument and Consumables
4.2.2: Market by Test: CBC (Hemoglobin, Hematocrit, and RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, and DPG
4.2.3: Market by End User: Hospitals, Diagnostic Labs, and Others
4.2.4: The United States Hematology Diagnostic Market
4.2.5: The Canadian Hematology Diagnostic Market
4.2.6: The Mexican Hematology Diagnostic Market
4.3: European Hematology Diagnostic Market
4.3.1: Market by Product: Instrument and Consumables
4.3.2: Market by Test: CBC (Hemoglobin, Hematocrit, and RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, and DPG
4.3.3: Market by End User: Hospitals, Diagnostic Labs, and Others
4.3.4: The United Kingdom Hematology Diagnostic Market
4.3.5: The Spanish Hematology Diagnostic Market
4.3.6: The German Hematology Diagnostic Market
4.3.7: The French Hematology Diagnostic Market
4.4: APAC Hematology Diagnostic Market
4.4.1: Market by Product: Instrument and Consumables
4.4.2: Market by Test: CBC (Hemoglobin, Hematocrit, and RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, and DPG
4.4.3: Market by End User: Hospitals, Diagnostic Labs, and Others
4.4.4: The Chinese Hematology Diagnostic Market
4.4.5: The Indian Hematology Diagnostic Market
4.4.6: The Japanese Hematology Diagnostic Market
4.5: ROW Hematology Diagnostic Market
4.5.1: Market by Product: Instrument and Consumables
4.5.2: Market by Test: CBC (Hemoglobin, Hematocrit, and RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, and DPG
4.5.3: Market by End User: Hospitals, Diagnostic Labs, and Others
4.5.5: Brazilian Hematology Diagnostic Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Hematology Diagnostic Market by Product
7.1.2: Growth Opportunities for the Global Hematology Diagnostic Market by Test
7.1.3: Growth Opportunities for the Global Hematology Diagnostic Market by End User
7.1.4: Growth Opportunities for the Global Hematology Diagnostic Market by Region
7.2: Emerging Trends in the Global Hematology Diagnostic Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Hematology Diagnostic Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hematology Diagnostic Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Abbott Laboratories
8.2: Beckman Coulter
8.3: Bio-Rad Laboratories
8.4: Boule Diagnostics
8.5: Horiba
8.6: Mindray Medical
8.7: Nihon Kohden Corporation
8.8: Roche Diagnostics
8.9: Siemens Healthcare
8.10: Sysmex Corporation
